We are testing whether nerandomilast can improve lung function in people with lung fibrosis related to rheumatic diseases. The study will also look at safety, including the risk of infections.
Health conditions and diseases that the clinical trial is designed to study and treat.
Systemic Autoimmune Rheumatic Diseases associated Interstitial Lung Diseases (SARD-ILD) refers to a group of conditions where autoimmune diseases, such as lupus or rheumatoid arthritis, lead to inflammation and scarring in the lungs, causing breathing difficulties.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.
